Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

CARBOCAINE Description (mepivacaine Hydrochloride Injection, USP)

DESCRIPTION

Mepivacaine hydrochloride is 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl, monohydrochloride and has the following structural formula:

structural formula carbocaine

                C15H22N2O • HCl

It is a white crystalline odorless powder, soluble in water, but very resistant to both acid and alkaline hydrolysis.

CARBOCAINE is a local anesthetic available as sterile isotonic solutions (clear, colorless) in concentrations of 1%, 1.5%, and 2% for injection via local infiltration, peripheral nerve block, and caudal and lumbar epidural blocks.

Mepivacaine hydrochloride is related chemically and pharmacologically to the amide-type local anesthetics. It contains an amide linkage between the aromatic nucleus and the amino group.

*
In Water for Injection.
The pH of the solution is adjusted between 4.5 and 6.8 with sodium hydroxide or hydrochloric acid.

Composition of Available Solutions*

1%

Single-Dose

30 mL Vial

mg/mL

1%

Multiple-Dose

50 mL Vial

mg/mL

1.5%

Single-Dose

30 mL Vial

mg/mL

2%

Single-Dose

20 mL Vial

mg/mL

2%

Multiple-Dose

50 mL Vial

mg/mL

Mepivacaine
hydrochloride

 
10

 
10

 
15

 
20

 

20

Sodium chloride

6.6

7

5.6

4.6

5

Potassium chloride

0.3

0.3

0.3

Calcium chloride

0.33

0.33

0.33

Methylparaben

1

1

Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event